Transition Therapeutics (TTHI)
Create an AlertTransition Therapeutics Enterprise Value:
68.33M for June 18, 2013Transition Therapeutics Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 18, 2013 | 68.33M |
| June 17, 2013 | 70.21M |
| June 14, 2013 | 69.40M |
| June 13, 2013 | 69.94M |
| June 12, 2013 | 70.75M |
| June 11, 2013 | 68.59M |
| June 10, 2013 | 68.86M |
| June 7, 2013 | 70.21M |
| June 6, 2013 | 70.21M |
| June 5, 2013 | 70.09M |
| June 4, 2013 | 72.63M |
| June 3, 2013 | 73.44M |
| May 31, 2013 | 65.09M |
| May 30, 2013 | 57.29M |
| May 29, 2013 | 56.48M |
| May 28, 2013 | 60.52M |
| May 24, 2013 | 58.36M |
| May 23, 2013 | 57.29M |
| May 22, 2013 | 56.48M |
| May 21, 2013 | 55.94M |
| May 20, 2013 | 51.63M |
| May 17, 2013 | 52.98M |
| May 16, 2013 | 52.44M |
| May 15, 2013 | 52.17M |
| May 14, 2013 | 52.17M |
| May 13, 2013 | 51.90M |
| May 10, 2013 | 49.21M |
| May 9, 2013 | 49.21M |
| May 8, 2013 | 54.86M |
| May 7, 2013 | 56.48M |
| May 6, 2013 | 56.48M |
| May 3, 2013 | 54.60M |
| May 2, 2013 | 48.94M |
| May 1, 2013 | 54.33M |
| April 30, 2013 | 58.36M |
| April 29, 2013 | 35.48M |
| April 26, 2013 | 33.87M |
| April 25, 2013 | 31.17M |
| April 24, 2013 | 30.64M |
| April 23, 2013 | 30.71M |
| April 22, 2013 | 29.83M |
| April 19, 2013 | 29.18M |
| April 18, 2013 | 28.48M |
| April 17, 2013 | 30.64M |
| April 16, 2013 | 27.14M |
| April 15, 2013 | 29.56M |
| April 12, 2013 | 30.64M |
| April 11, 2013 | 30.10M |
| April 10, 2013 | 30.37M |
| April 9, 2013 | 30.64M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
TTHI Enterprise Value Benchmarks
| Companies | |
|---|---|
| ARCA biopharma | 0.668M |
| Advanced Proteome Therpt | 9.651M |
| Clinuvel Pharmaceuticals |
TTHI Enterprise Value Rankings
| Overall |
68th percentile 5322 of 16770 |
| Sector |
64th percentile 497 of 1408 in Healthcare |
| Industry |
63rd percentile 165 of 453 in Biotechnology |
TTHI Enterprise Value Range, Past 5 Years
| Minimum | 13.05M | Dec 20 2011 |
| Maximum | 161.33M | Sep 23 2009 |
| Average | 48.10M |
